Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Penile Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 21Nivolumab 7Docetaxel 7Paclitaxel 5Magnetic Resonance Spectroscopy 5Carboplatin 5Trastuzumab 4Specimen Handling 4Psychiatric Rehabilitation 4Cyclophosphamide 4tisotumab vedotin 3fludarabine 3atezolizumab 3Taxes 3Polymerase Chain Reaction 3Gene Expression Profiling 3Gemcitabine 3Fluorouracil 3Counseling 3Cisplatin 3Albumin-Bound Paclitaxel 3ulixertinib 2poly ICLC 2durvalumab 2belinostat 2X-Rays 2Standard of Care 2Radiotherapy 2Radiation 2Oxaliplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × oncogene protein E7, Human papillomavirus type 16 × Genitourinary × Clear all
NCT00019110 2015-04-29

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

National Cancer Institute (NCI)

Phase 1 Completed
CNSGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Penile Neoplasms, Salivary Gland Neoplasms, Vulvar Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡